Lowe Brockenbrough & CO Inc Amgen Inc Transaction History

Lowe Brockenbrough & CO Inc

$1.55 Billion
Q3 2024

A detailed history of Lowe Brockenbrough & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Lowe Brockenbrough & CO Inc holds 24,636 shares of AMGN stock, worth $6.55 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

24,636

Previous 34,031 27.61%

Holding current value

$6.55 Million

Previous $10.6 Million 25.35%

% of portfolio

0.51%

Previous 0.71%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$309.38 - $337.38 $2.91 Million - $3.17 Million	-9,395 Reduced 27.61%	24,636 $7.94 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $12,349 - $15,007	-47 Reduced 0.14%	34,031 $10.6 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $2.43 Million - $2.93 Million	9,033 Added 36.07%	34,078 $9.69 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $2.87 Million - $3.23 Million	-11,205 Reduced 30.91%	25,045 $7.21 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $29,955 - $37,190	-137 Reduced 0.38%	36,250 $9.74 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $698,734 - $826,239	3,261 Added 9.84%	36,387 $8.08 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $441,645 - $538,291	1,956 Added 6.28%	33,126 $8.01 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $371,944 - $472,600	-1,624 Reduced 4.95%	31,170 $8.19 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $318,508 - $359,219	-1,419 Reduced 4.15%	32,794 $7.39 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $87,900 - $97,817	-381 Reduced 1.1%	34,213 $8.32 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $167,741 - $185,566	-765 Reduced 2.16%	34,594 $8.37 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $115,350 - $132,008	580 Added 1.67%	35,359 $7.96 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $655,914 - $768,483	3,090 Added 9.75%	34,779 $7.4 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $120,760 - $133,975	517 Added 1.66%	31,689 $7.72 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $94,311 - $109,905	425 Added 1.38%	31,172 $7.76 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $44,141 - $52,564	204 Added 0.67%	30,747 $7.07 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $79,077 - $87,940	-337 Reduced 1.09%	30,543 $7.76 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $83,278 - $102,193	-421 Reduced 1.35%	30,880 $7.28 Million
Q1 2020 May 21, 2020	SELL	$182.24 - $241.7 $67,246 - $89,187	-369 Reduced 1.17%	31,301 $6.35 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $244,080 - $313,728	1,290 Added 4.25%	31,670 $7.64 Million
Q3 2019 Nov 21, 2019	BUY	$174.11 - $208.62 $26,987 - $32,336	155 Added 0.51%	30,380 $5.88 Million
Q2 2019 Aug 12, 2019	BUY	$166.7 - $195.41 $25,505 - $29,897	153 Added 0.51%	30,225 $5.57 Million
Q1 2019 May 21, 2019	BUY	$180.87 - $203.88 $12,480 - $14,067	69 Added 0.23%	30,072 $5.71 Million
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $58,872 - $68,722	-330 Reduced 1.09%	30,003 $5.84 Million
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $27,793 - $31,333	-150 Reduced 0.49%	30,333 $6.29 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $235,292 - $264,284	1,417 Added 4.88%	30,483 $5.63 Million
Q1 2018 Apr 30, 2018	SELL	$169.43 - $198.0 $51,676 - $60,390	-305 Reduced 1.04%	29,066 $4.96 Million
Q4 2017 Jan 30, 2018	SELL	$168.79 - $188.59 $16,035 - $17,916	-95 Reduced 0.32%	29,371 $5.11 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $4.93 Million - $5.63 Million	29,466	29,466 $5.49 Million

Others Institutions Holding AMGN

# of Institutions

3,126

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowe Brockenbrough & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lowe Brockenbrough & CO Inc with notifications on news.

Account

Lowe Brockenbrough & CO Inc Amgen Inc Transaction History